# Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers

> **NCT06001372** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 2 (actual)

## Conditions studied

- Gastrointestinal Cancer
- Depression
- Anxiety

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT06001372
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-13
- **Primary completion:** 2023-12-22
- **Final completion:** 2024-03-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Challenges with feasibility
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06001372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06001372, "Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06001372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*